Karo Pharma: Interim Report January - March 2016

HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News:

Karo Pharma (STO:KARO)

FIRST QUARTER

· Net sales amounted to MSEK 82.3 (0.4)

· Earnings before depreciation were MSEK 9.3 (-14.9)